The breast cancer patient in the cardioncology unit

Area of Science:

• Cardiology
• Oncology
• Cardio-oncology

Background:

• Breast cancer management advances have improved survival rates.
• Cardiovascular side effects are a significant concern, becoming the leading cause of mortality in older breast cancer survivors.
• Managing cardiovascular risk is critical to prevent treatment-induced morbidity and mortality.

Purpose of the Study:

• To highlight the importance of cardioncology in managing cardiovascular risks associated with breast cancer therapy.
• To discuss strategies for risk stratification, early diagnosis, prevention, and treatment of cardiotoxicity.
• To emphasize the interdisciplinary approach needed to minimize long-term cardiovascular disease in cancer patients.

Main Methods:

• This review discusses the advantages of a cardioncology approach.
• It covers risk stratification, monitoring for early diagnosis, prevention, and early treatment of cardiotoxicity.
• The review emphasizes evidence-based indications and interdisciplinary expertise.

Main Results:

• Cardioncology facilitates a proactive approach to cardiovascular health in breast cancer patients.
• Early identification and management of cardiotoxicity can mitigate severe side effects.
• An integrated cardiology-oncology strategy can prevent long-term heart disease and preserve therapeutic options.

Conclusions:

• Cardioncology is essential for optimizing breast cancer treatment outcomes while preserving cardiac health.
• Interdisciplinary collaboration is key to reducing cardiovascular morbidity and mortality.
• Preventing 'the heart patient of tomorrow' is a primary goal of modern cancer care.